{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Nrf2", "bronchial asthma", "chemotherapy-induced peripheral neuropathy (CIPN)", "oxidative stress", "ozone therapy", "pain", "rheumathoid arthritis"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36814483", "DateRevised": {"Year": "2023", "Month": "02", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "02", "Day": "06"}], "ELocationID": ["1112860", "10.3389/fphys.2023.1112860"], "Journal": {"ISSN": "1664-042X", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in physiology", "ISOAbbreviation": "Front Physiol"}, "ArticleTitle": "Editorial: Ozone in medicine: Biochemical background, physiological modulation and clinical applications.", "Pagination": {"StartPage": "1112860", "MedlinePgn": "1112860"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Unit, Chronic Pain Unit, and Radiation Oncology Department, Hospital Universitario de Gran Canaria Dr. Negr\u00edn, Las Palmas, Spain."}, {"Identifier": [], "Affiliation": "Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias (FIISC), Las Palmas, Spain."}, {"Identifier": [], "Affiliation": "Instituto Universitario de Enfermedades Tropicales y Salud P\u00fablica de Canarias de la Universidad de La Laguna, Tenerife, Spain."}], "LastName": "Clavo", "ForeName": "Bernardino", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnologies, University of Siena, Siena, Italy."}, {"Identifier": [], "Affiliation": "Postgraduate Course on Oxygen Ozone Therapy, University of Siena, Siena, Italy."}], "LastName": "Borrelli", "ForeName": "Emma", "Initials": "E"}], "PublicationTypeList": ["Editorial"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Physiol", "NlmUniqueID": "101549006", "ISSNLinking": "1664-042X"}, "CommentsCorrectionsList": [{"RefSource": "Editorial on the Research Topic Ozone in medicine: Biochemical background, physiological modulation and clinical applications"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bocci V. A., Zanardi I., Travagli V. (2011). Ozone acting on human blood yields a hormetic dose-response relationship. J. Transl. Med. 9, 66. 10.1186/1479-5876-9-66", "ArticleIdList": ["10.1186/1479-5876-9-66", "PMC3125221", "21575276"]}, {"Citation": "Bocci V., Borrelli E., Travagli V., Zanardi I. (2009). The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med. Res. Rev. 29 (4), 646\u2013682. 10.1002/med.20150", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Bocci V. (2011). Ozone. A new medical drug. Berlin, Germany: Springer-Verlag, 315."}, {"Citation": "Borrelli E. (2021). The problem of chronic oxidative stress and the systemic indirect ozone therapy as a possible solution. Highlight Med. Med. Res. 4, 135\u2013140. 10.9734/bpi/hmmr/v4/1739F", "ArticleIdList": ["10.9734/bpi/hmmr/v4/1739F"]}, {"Citation": "Calabrese E. J., Kozumbo W. J. (2021). The hormetic dose-response mechanism: Nrf2 activation. Pharmacol. Res. 167, 105526. 10.1016/j.phrs.2021.105526", "ArticleIdList": ["10.1016/j.phrs.2021.105526", "33667690"]}, {"Citation": "Chu K.-H., Tung H.-H., Clinciu D. L., Hsu H.-I., Wu Y.-C., Hsu C.-I., et al. (2022). A preliminary study on self-healing and self-health management in older adults: Perspectives from healthcare professionals and older adults in Taiwan. Gerontology Geriatric Med. 8, 23337214221077788. 10.1177/23337214221077788", "ArticleIdList": ["10.1177/23337214221077788", "PMC8958667", "35356303"]}, {"Citation": "Markham M. J., Wachter K., Agarwal N., Bertagnolli M. M., Chang S. M., Dale W., et al. (2020). Clinical cancer advances 2020: Annual report on progress against cancer from the American society of clinical Oncology. J. Clin. Oncol. 38 (10), 1081. 10.1200/JCO.19.03141", "ArticleIdList": ["10.1200/JCO.19.03141", "32013670"]}, {"Citation": "Milkovic L., Zarkovic N., Saso L. (2017). Controversy about pharmacological modulation of Nrf2 for cancer therapy. Redox Biol. 12, 727\u2013732. 10.1016/j.redox.2017.04.013", "ArticleIdList": ["10.1016/j.redox.2017.04.013", "PMC5393166", "28411557"]}, {"Citation": "Rojo de la Vega M., Chapman E., Zhang D. D. (2018). NRF2 and the hallmarks of cancer. Cancer Cell 34 (1), 21\u201343. 10.1016/j.ccell.2018.03.022", "ArticleIdList": ["10.1016/j.ccell.2018.03.022", "PMC6039250", "29731393"]}, {"Citation": "Tanner B. D., Suwahara S., Gerba C. P., Reynolds K. A. (2004). Evaluation of electrochemically generated ozone for the disinfection of water and wastewater. Water Sci. Technol. 50 (1), 19\u201325. 10.2166/wst.2004.0007", "ArticleIdList": ["10.2166/wst.2004.0007", "15318481"]}, {"Citation": "Yerkes R., Dodson J. (1908). The relation of strength of stimulus to rapidity of habit-formation. J. Comp. Neurology Psychol. 18 (5), 459\u2013482. 10.1002/cne.920180503", "ArticleIdList": ["10.1002/cne.920180503"]}, {"Citation": "Zhang S. (2021). Chemotherapy-induced peripheral neuropathy and rehabilitation: A review. Semin. Oncol. 48 (3), 193\u2013207. 10.1053/j.seminoncol.2021.09.004", "ArticleIdList": ["10.1053/j.seminoncol.2021.09.004", "34607709"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "30"}, {"Year": "2023", "Month": "1", "Day": "27"}, {"Year": "2023", "Month": "2", "Day": "23", "Hour": "2", "Minute": "4"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["36814483", "PMC9939878", "10.3389/fphys.2023.1112860", "1112860"]}}], "PubmedBookArticle": []}